Autolus Therapeutics Director Linda Bain Receives Equity Awards

This Form 4 filing reports equity awards granted to Linda Bain, a director of Autolus Therapeutics plc. On June 29, 2026, Bain received two equity awards: 31,667 restricted share units (RSUs) and 47,500 share options. The RSUs represent a contingent right to receive American Depositary Shares and vest in one installment on June 29, 2027. The share options have an exercise price of $1.61 per share, vest in twelve equal monthly installments beginning July 29, 2026, and expire on June 29, 2036. Both awards were granted at $0 cost to the director. Following these transactions, Bain holds 31,667 RSUs and 47,500 share options. The filing demonstrates the company's ongoing compensation practices for board members through equity-based incentives.